PE-22-28 is a short peptide fragment derived from DBI that works by modulating GABA-A receptors in the brain. It enhances GABA signaling in a way similar to benzodiazepines, but without binding directly to the traditional benzodiazepine receptor site. Because of this, it is designed to promote calming and anti-anxiety effects without causing sedation, dependency, or tolerance. Its unique binding profile allows it to support relaxation and emotional balance while avoiding the common side effects associated with conventional anti-anxiety medications.
Research suggests PE-22-28 may reduce anxiety, improve mood, and enhance stress resilience by supporting healthy neurotransmitter balance and neuroplasticity. It has also shown potential neuroprotective benefits, including protection against oxidative stress and excitotoxicity, and may support recovery from chronic stress, PTSD, or brain injury. Emerging applications include generalized anxiety, social anxiety, cognitive performance under stress, and possibly long-term brain health support.
Reconstitution Protocol
- Diluent/Amount: 2ML Bacteriostatic Water
Dosage Instructions
- Dosage Range: 100mcg – 500mcg (2 units-10units)
- Dosage Frequency: Morning or early evening.
- Route: Subcutaneous
- Cycle Duration: 4-6 weeks
- Est. Bottles needed to complete Cycle: 1-2 Bottles
Notes
- Morning administration may enhance mood and mental clarity.
Peptides to Stack with PE-22-28:
- Selank: Reduces anxiety while PE-22-28 improves mood via neurotrophic pathways.
- Semax: Enhances focus and cognitive performance; mood + drive synergy.
- NAD+: Supports neuronal energy metabolism for sustained mood resilience.
- SS-31: Protects against neuroinflammation contributing to depressive states.
- MOTS-C: Supports metabolic resilience, which can improve stress tolerance and mood stability.